Authors: JACKSON DM WALLSTEN CE JERNING E HU PS DEVENEY AM

Citation: Dm. Jackson et al., 2 SELECTIVE 5-HT1A RECEPTOR ANTAGONISTS, WAY-100-635 AND NDL-249, STIMULATE LOCOMOTION IN RATS ACCLIMATIZED TO THEIR ENVIRONMENT AND ALTER THEIR BEHAVIOR - A BEHAVIORAL-ANALYSIS, Psychopharmacology, 139(4), 1998, pp. 300-310

Authors: JERNING E SVANTESSON GT MOHELL N

Citation: E. Jerning et al., RECEPTOR-BINDING CHARACTERISTICS OF [H-3]NAD-299, A NEW SELECTIVE 5-HT1A RECEPTOR ANTAGONIST, European journal of pharmacology, 360(2-3), 1998, pp. 219-225

Authors: HALL H HALLDIN C JERNING E OSTERLUND M FARDE L SEDVALL G

Citation: H. Hall et al., AUTORADIOGRAPHIC COMPARISON OF [I-125] EPIDEPRIDE AND [I-125] NCQ-298BINDING TO HUMAN BRAIN EXTRASTRIATED DOPAMINE-RECEPTORS, Nuclear medicine and biology, 24(5), 1997, pp. 389-393

Authors: JOHANSSON L SOHN D THORBERG SO JACKSON DM KELDER D LARSSON LG RENYI L ROSS SB WALLSTEN C ERIKSSON H HU PS JERNING E MOHELL N WESTLINDDANIELSSON A

Citation: L. Johansson et al., THE PHARMACOLOGICAL CHARACTERIZATION OF A NOVEL SELECTIVE 5-HYDROXYTRYPTAMINE(1A) RECEPTOR ANTAGONIST, NAD-299, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 216-225

Authors: MALMBERG A JERNING E MOHELL N

Citation: A. Malmberg et al., CRITICAL REEVALUATION OF SPIPERONE AND BENZAMIDE BINDING TO DOPAMINE D-2 RECEPTORS - EVIDENCE FOR IDENTICAL BINDING-SITES, European journal of pharmacology, 303(1-2), 1996, pp. 123-128

Authors: JERNING E MALMBERG A MOHELL N

Citation: E. Jerning et al., IN-VITRO RECEPTOR-BINDING CHARACTERISTICS OF THE NEW DOPAMINE D-2 ANTAGONIST [I-125] NCQ-298 - METHODOLOGICAL CONSIDERATIONS OF HIGH-AFFINITY BINDING, Journal of receptor and signal transduction research, 15(1-4), 1995, pp. 503-515